Kenya on Friday received 141,000 single-shot Johnson & Johnson vaccines as it races to vaccine at least 10 million Kenyans by December this year.
The consignment was received at the JKIA by senior government officials led by Health CAS Dr Mercy Mwangangi.
The Johnson & Johnson vaccine is the third vaccine in Kenya’s programme with AstraZeneca and Moderna vaccines already being administered in the country.
“The Johnson & Johnson vaccine is easily stored between two and eight degrees centigrade during administration and can also be frozen at -20 degrees to ensure there is lengthening of shelf-life. This vaccine, therefore, requires less logistics and operational cost,” Dr Mwangangi said.
She added that the single shot vaccine will be of great utility to the country, especially when reaching the primary healthcare level of the health system where the uptake of the vaccine is low.
By close of business on Friday, 2,809,389 vaccinations had been administered in the country, with 2,020,009 being first doses, while 809,380 people had been fully vaccinated. This represents 2.97 per cent of the entire adult population.
“The single dose administration will ensure these populations will be fully vaccinated quickly. The Ministry of Health will therefore prioritize the distribution of the Johnson and Johnson vaccine towards the primary healthcare level,” she said.
On Saturday, some 55,000 more doses of AstraZeneca vaccine donated by Latvia arrived in the country.
The arrival of the Johnson and Johnson vaccine and the donation by Latvia means Kenya has now received a total of 4,266,500 Covid-19 vaccine doses.
The Ministry of Health also announced it has finalized training of regional depot managers and health workers on handling procedures of the various vaccines authorised to be used in the country.